David H Epstein, Ph.D.

Trials

Studies that name David H Epstein, Ph.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:57 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT06995885 · Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl

  National Institute on Drug Abuse (NIDA) · enrolling by invitation · Substance Use Disorders (SUDs) · principal investigator
• N/A
  NCT05457803 · Real-world Momentary Assessment of Kratom Use Accompanied by Product Assays: A Natural-history Study for Interdisciplinary Characterization of Kratom Use and Pharmacology

  National Institute on Drug Abuse (NIDA) · completed · Chronic Pain, Fatigue, Substance Use Disorders · principal investigator
• Ph2
  NCT04316559 · Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD

  National Institute on Drug Abuse (NIDA) · terminated · Opioid-Use Disorder · principal investigator
• N/A
  NCT03538652 · Just-In-Time Adaptive Interventions for Addictive Behaviors

  National Institute on Drug Abuse (NIDA) · terminated · Addiction · principal investigator
• Early Ph1
  NCT01656577 · Pexacerfont for Stress-induced Food Craving

  National Institute on Drug Abuse (NIDA) · terminated · Daily Oral Pexacerfont for 28 Days (300 mg/Day Loading Dose for 7 Days, Followed, Placebo · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 07:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.